Skip to main content
. 2008 Jan 21;14(3):454–462. doi: 10.3748/wjg.14.454

Table 2.

The type and frequency of adverse events reported in the 22 studies included in the analysis (n = 1279)

Adverse events Number of adverse events Percentage 95% CI
Distention 9 0.70 0.32-1.34
Diarrhea 8 0.63 0.27-1.23
Abdominal pain 6 0.47 0.17-1.02
Constipation 5 0.39 0.13-0.91
Dizziness and sleepiness 4 0.31 0.09-0.80
Headaches 4 0.31 0.09-0.80
Nausea 3 0.23 0.05-0.69
Gastrointestinal discomfort 1 0.08 0.002-0.44
Upper gastrointestinal discomfort 1 0.08 0.002-0.44
Loss of hair 1 0.08 0.002-0.44
Pruritus 1 0.08 0.002-0.44
Paraesthesia 1 0.08 0.002-0.44
Disturbance 1 0.08 0.002-0.44
Hoarseness 1 0.08 0.002-0.44
Shortness of breath and chest pain 1 0.08 0.002-0.44
Total 47 3.67 2.73-4.87